Andrew Simpson Files Schedule 13D/A for HeartSciences Inc.
Andrew Simpson filed a Schedule 13D/A with the SEC regarding HeartSciences Inc. on October 23, 2026, indicating a change in beneficial ownership.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Andrew Simpson filed a Schedule 13D/A with the SEC regarding HeartSciences Inc. on October 23, 2026, indicating a change in beneficial ownership.
HeartSciences Inc. has filed its definitive proxy statement with the SEC regarding its previously announced business combination with Fortitude Mining Holdings, Inc.